Literature DB >> 12441049

The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease.

Cherie M Southwood1, James Garbern, Wei Jiang, Alexander Gow.   

Abstract

The unfolded protein response (UPR) is a eukaryotic signaling pathway linking protein flux through the endoplasmic reticulum to transcription and translational repression. Herein, we demonstrate UPR activation in the leukodystrophy Pelizaeus-Merzbacher disease (PMD) as well as in three mouse models of this disease and transfected fibroblasts expressing mutant protein. The CHOP protein, widely known as a proapoptotic transcription factor, modulates pathogenesis in the mouse models of PMD; however, this protein exhibits antiapoptotic activity. Together, these data show that the UPR has the potential to modulate disease severity in many cells expressing mutant secretory pathway proteins. Thus, PMD represents the first member of a novel class of disparate degenerative diseases for which UPR activation and signaling is the common pathogenic mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441049      PMCID: PMC4603660          DOI: 10.1016/s0896-6273(02)01045-0

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  50 in total

1.  Major histocompatibility complex heavy chain accumulation in the endoplasmic reticulum of oligodendrocytes results in myelin abnormalities.

Authors:  K D Baerwald; J G Corbin; B Popko
Journal:  J Neurosci Res       Date:  2000-01-15       Impact factor: 4.164

2.  The rumpshaker mutation in spastic paraplegia.

Authors:  H Kobayashi; E P Hoffman; H G Marks
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330

3.  Jimpy(msd) mouse mutation and connatal Pelizaeus-Merzbacher disease.

Authors:  T Yamamoto; E Nanba; H Zhang; M Sasaki; H Komaki; K Takeshita
Journal:  Am J Med Genet       Date:  1998-02-03

4.  Major histocompatibility complex class I expression in oligodendrocytes induces hypomyelination in transgenic mice.

Authors:  C Power; P A Kong; B D Trapp
Journal:  J Neurosci Res       Date:  1996-04-15       Impact factor: 4.164

5.  Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response.

Authors:  T Katayama; K Imaizumi; N Sato; K Miyoshi; T Kudo; J Hitomi; T Morihara; T Yoneda; F Gomi; Y Mori; Y Nakano; J Takeda; T Tsuda; Y Itoyama; O Murayama; A Takashima; P St George-Hyslop; M Takeda; M Tohyama
Journal:  Nat Cell Biol       Date:  1999-12       Impact factor: 28.824

6.  Conservative amino acid substitution in the myelin proteolipid protein of jimpymsd mice.

Authors:  S Gencic; L D Hudson
Journal:  J Neurosci       Date:  1990-01       Impact factor: 6.167

7.  The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin.

Authors:  B Stecca; C M Southwood; A Gragerov; K A Kelley; V L Friedrich; A Gow
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

Review 8.  Transgenic systems in studying myelin gene expression.

Authors:  K Ikenaka; T Kagawa
Journal:  Dev Neurosci       Date:  1995       Impact factor: 2.984

9.  Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse.

Authors:  L D Hudson; J A Berndt; C Puckett; C A Kozak; R A Lazzarini
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

10.  Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease.

Authors:  A Gow; C M Southwood; R A Lazzarini
Journal:  J Cell Biol       Date:  1998-02-23       Impact factor: 10.539

View more
  98 in total

1.  Attenuating the endoplasmic reticulum stress response improves functional recovery after spinal cord injury.

Authors:  Sujata Saraswat Ohri; Melissa A Maddie; Yongmei Zhao; Mengsheng S Qiu; Michal Hetman; Scott R Whittemore
Journal:  Glia       Date:  2011-06-02       Impact factor: 7.452

Review 2.  The unfolded protein response in protein aggregating diseases.

Authors:  Alexander Gow; Ramaswamy Sharma
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

3.  Chemical stress induces the unfolded protein response in olfactory sensory neurons.

Authors:  Neeraja Sammeta; Timothy S McClintock
Journal:  J Comp Neurol       Date:  2010-05-15       Impact factor: 3.215

4.  Genetic background influences UPR but not PLP processing in the rumpshaker model of PMD/SPG2.

Authors:  M McLaughlin; S A Karim; P Montague; J A Barrie; D Kirkham; I R Griffiths; J M Edgar
Journal:  Neurochem Res       Date:  2006-08-31       Impact factor: 3.996

5.  Therapeutic strategies for the inherited neuropathies.

Authors:  Michael E Shy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

6.  Insertion of proteolipid protein into oligodendrocyte mitochondria regulates extracellular pH and adenosine triphosphate.

Authors:  Sunita Appikatla; Denise Bessert; Icksoo Lee; Maik Hüttemann; Chadwick Mullins; Mallika Somayajulu-Nitu; Fayi Yao; Robert P Skoff
Journal:  Glia       Date:  2013-12-31       Impact factor: 7.452

7.  Novel alternatively spliced endoplasmic reticulum retention signal in the cytoplasmic loop of Proteolipid Protein-1.

Authors:  Cherie Southwood; Kevin Olson; Chia-Yen Wu; Alexander Gow
Journal:  J Neurosci Res       Date:  2007-02-15       Impact factor: 4.164

8.  Unfolded protein response in a Drosophila model for retinal degeneration.

Authors:  Hyung Don Ryoo; Pedro M Domingos; Min-Ji Kang; Hermann Steller
Journal:  EMBO J       Date:  2006-12-14       Impact factor: 11.598

9.  Insertion of proteolipid protein into mitochondria but not DM20 regulates metabolism of cells.

Authors:  Mallika Somayajulu; Denise A Bessert; Maik Hüttemann; Jasloveleen Sohi; John Kamholz; Robert P Skoff
Journal:  Neurosci Lett       Date:  2018-05-02       Impact factor: 3.046

10.  Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma.

Authors:  Wensheng Lin; Phillip E Kunkler; Heather P Harding; David Ron; Richard P Kraig; Brian Popko
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.